Clinical Trials Browser

Phase 2 × Fanconi Anemia, Complementation Group D1 × liposomal doxorubicin × Clear all

NCT00628251 2019-12-05

ICEBERG 3

Phase 2 Completed

97 enrolled 22 charts

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms